ArticleFrontiers in genetics2026
A deep learning model for predicting essential proteins based on an attention mechanism.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Essential proteins are key to cellular viability, yet their experimental identification is costly and time-consuming. Methods: In this study, DLAM is introduced as a deep learning framework that integrates four complementary biological cues, namely, domain composition, subcellular localization, orthology, and gene expression, together with a weighted protein-protein interaction network. The heterogeneous signals are encoded into compact representations and learned by an attention-enhanced network to score protein essentiality. Results: On the DIP dataset, DLAM achieves consistently better performance than representative centrality measures and conventional machine-learning classifiers. In a further expanded baseline study based on the larger BioGRID dataset containing more proteins, we conducted comparative experiments between DLAM and four recently proposed deep learning methods (TCBB2021, EPGAT, BMC2022, and ACDMBI). On the BioGRID dataset, we evaluated DLAM using stratified five-fold cross-validation. Across folds, DLAM achieves consistently strong discrimination and ranking performance (reported as the mean ± std. for ROC-AUC and AP) and maintains a stable F1-score under a validation-selected decision threshold. This suggests that, under the same evaluation protocol, DLAM has strong ranking and discrimination capability. Moreover, it also exhibits good and stable performance on other metrics such as accuracy, precision, recall, and F-measure. Discussion: These results indicate that jointly modeling multi-source biological information with interaction topology yields more reliable essential-protein prediction under class imbalance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.